BioNTech SE
BNTX
$128.20
-$1.19-0.92%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/24/2023
-
Ticker Report
3/23/2023
-
24/7 Wall St.
3/21/2023
-
Simply Wall St
3/21/2023
-
Zacks Investment Research
3/20/2023
-
Zacks Investment Research
3/20/2023
-
Zolmax
3/20/2023
-
Globe Newswire
3/18/2023
-
Ticker Report
3/18/2023
-
Ticker Report
3/17/2023
-
InvestorPlace
3/16/2023
-
Ticker Report
3/16/2023
-
Zolmax
3/15/2023
-
Zacks Investment Research
3/15/2023
-
Ticker Report
3/14/2023
-
Zacks Investment Research
3/13/2023
-
Zacks Investment Research
3/13/2023
-
Globe Newswire
3/10/2023
-
Zacks Investment Research
3/9/2023
-
ETF Channel
3/7/2023
-
Ticker Report
3/6/2023
-
Zacks Investment Research
3/5/2023
-
Simply Wall St
3/3/2023
-
Zolmax
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 7, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Mar 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
49 6131 9084 0
Address
An der Goldgrube 12
Mainz, 55131
Mainz, 55131
Country
Year Founded
Business Description
Sector
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111...
more
